Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3998991 | Surgical Oncology Clinics of North America | 2008 | 20 Pages |
Abstract
In intraductal and papillary mucinous neoplasm (IPMN) of the pancreas, the aims of surgery differ according to the presence of malignancy. For malignant IPMN and especially for invasive malignancy, radical resection is essential, but entails a substantial operative risk and long-term pancreatic insufficiency. For benign IPMN, in theory, the operative risk and the loss of pancreatic function should be minimal. Thus, surgery for malignant and benign IPMN differs in patient selection, surgical technique, and accepted risk of long-term functional disorders. This article details the indications, surgical techniques, and results of surgery in IPMN.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Alain Sauvanet,